Search for another bill

Search for another bill or initiative


SB 5916 - 2025-26

Concerning nonopioid drugs for the treatment of pain.
Sponsors: Harris, Chapman, SaldaƱa

Bill status-at-a-glance

As of Saturday, March 7, 2026 01:23 AM

Current version:

Engrossed substitute - ESSB 5916

Current status:

HHC/Wellness

Where is it in the process?

IntroducedIn committeeOn floorcalendarPassedchamberIn the Senate:In the House:
After passage:PassedLegislatureOn Governor'sdeskGovernoractedSession law

Bill status-at-a-glance

As of Saturday, March 7, 2026 01:23 AM

Current version:

Engrossed substitute - ESSB 5916

Current status:

HHC/Wellness

Where is it in the process?

IntroducedIn committeeOn floorcalendarPassedchamber
Senate:
House:
PassedLegislatureOn Governor'sdeskGovernoractedSession law
AfterPassage:

Bill history

2026 Regular Session

In the Senate

Dec 17
Prefiled for introduction.
Jan 12
First reading, referred to Health & Long-Term Care. (View original bill)
Jan 20
Public hearing in the Senate Committee on Health & Long-Term Care at 10:30 AM. (Committee materials)
Jan 27
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM. (Committee materials)
HLTC - Majority; 1st substitute bill be substituted, do pass. (View 1st substitute) (Majority report)
Jan 28
Passed to Rules Committee for second reading.
Feb 4
Placed on second reading by Rules Committee.
Feb 11
1st substitute bill substituted (HLTC 26). (View 1st substitute)
Floor amendment(s) adopted.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (View 1st engrossed) (View this roll call)

In the House

Feb 14
First reading, referred to Health Care & Wellness.

Available documents

For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.

Fiscal note

Amendments

Available videos